The DOI matches its Crossref record; 102 of the 102 references it cites were found in a registry or an index.
Intraoperative Imaging-Guided Cancer Surgery: From Current Fluorescence Molecular Imaging Methods to Future Multi-Modality Imaging Technology
Open accessAbstract
Cancer is a major threat to human health. Diagnosis and treatment using precision medicine is expected to be an effective method for preventing the initiation and progression of cancer. Although anatomical and functional imaging techniques such as radiography, computed tomography (CT), magnetic resonance imaging (MRI) and positron emission tomography (PET) have played an important role for accurate preoperative diagnostics, for the most part these techniques cannot be applied intraoperatively. Optical molecular imaging is a promising technique that provides a high degree of sensitivity and specificity in tumor margin detection. Furthermore, existing clinical applications have proven that optical molecular imaging is a powerful intraoperative tool for guiding surgeons performing precision procedures, thus enabling radical resection and improved survival rates. However, detection depth limitation exists in optical molecular imaging methods and further breakthroughs from optical to multi-modality intraoperative imaging methods are needed to develop more extensive and comprehensive intraoperative applications. Here, we review the current intraoperative optical molecular imaging technologies, focusing on contrast agents and surgical navigation systems, and then discuss the future prospects of multi-modality imaging technology for intraoperative imaging-guided cancer surgery.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
In vivo imaging of tumors with protease-activated near-infrared fluorescent probes
Weissleder, R., Tung, C.-H., Mahmood, U., & Bogdanov, A. (1999) · Nature Biotechnology · doi:10.1038/7933 · Cited by 1,591
van Dam, G. M., Themelis, G., Crane, L. M. A., Harlaar, N. J., Pleijhuis, R. G., Kelder, W., Sarantopoulos, A., de Jong, J. S., Arts, H. J. G., van der Zee, A. G. J., et al. (2011) · Nature Medicine · doi:10.1038/nm.2472 · Cited by 1,545
Image-guided cancer surgery using near-infrared fluorescence
Vahrmeijer, A. L., Hutteman, M., van der Vorst, J. R., van de Velde, C. J. H., & Frangioni, J. V. (2013) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2013.123 · Cited by 1,466
Kircher, M. F., de la Zerda, A., Jokerst, J. V., Zavaleta, C. L., Kempen, P. J., Mittra, E., Pitter, K., Huang, R., Campos, C., Habte, F., et al. (2012) · Nature Medicine · doi:10.1038/nm.2721 · Cited by 1,064
What Is the Role for the Circumferential Margin in the Modern Treatment of Rectal Cancer?
Nagtegaal, I. D., & Quirke, P. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.12.7027 · Cited by 1,006
Real‐time identification of liver cancers by using indocyanine green fluorescent imaging
Ishizawa, T., Fukushima, N., Shibahara, J., Masuda, K., Tamura, S., Aoki, T., Hasegawa, K., Beck, Y., Fukayama, M., & Kokudo, N. (2009) · Cancer · doi:10.1002/cncr.24291 · Cited by 852
Troyan, S. L., Kianzad, V., Gibbs-Strauss, S. L., Gioux, S., Matsui, A., Oketokoun, R., Ngo, L., Khamene, A., Azar, F., & Frangioni, J. V. (2009) · Annals of Surgical Oncology · doi:10.1245/s10434-009-0594-2 · Cited by 684
Fluorescence navigation with indocyanine green for detecting sentinel lymph nodes in breast cancer
Kitai, T., Inomoto, T., Miwa, M., & Shikayama, T. (2005) · Breast Cancer · doi:10.2325/jbcs.12.211 · Cited by 640
Olson, E. S., Jiang, T., Aguilera, T. A., Nguyen, Q. T., Ellies, L. G., Scadeng, M., & Tsien, R. Y. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0910283107 · Cited by 567
Fluorescence-guided surgery with live molecular navigation — a new cutting edge
Nguyen, Q. T., & Tsien, R. Y. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3566 · Cited by 553
Cited by
Near‐Infrared‐II Molecular Dyes for Cancer Imaging and Surgery
Zhu, S., Tian, R., Antaris, A. L., Chen, X., & Dai, H. (2019) · Advanced Materials · doi:10.1002/adma.201900321 · Cited by 972
Self-citationBeyond the margins: real-time detection of cancer using targeted fluorophores
Zhang, R. R., Schroeder, A. B., Grudzinski, J. J., Rosenthal, E. L., Warram, J. M., Pinchuk, A. N., Eliceiri, K. W., Kuo, J. S., & Weichert, J. P. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.212 · Cited by 485
Ni, X., Zhang, X., Duan, X., Zheng, H.-L., Xue, X.-S., & Ding, D. (2019) · Nano Letters · doi:10.1021/acs.nanolett.8b03936 · Cited by 483
Layered double hydroxide-based nanomaterials for biomedical applications
Hu, T., Gu, Z., Williams, G. R., Strimaite, M., Zha, J., Zhou, Z., Zhang, X., Tan, C., & Liang, R. (2022) · Chemical Society Reviews · doi:10.1039/d2cs00236a · Cited by 440
The evolution of cancer surgery and future perspectives
Wyld, L., Audisio, R. A., & Poston, G. J. (2015) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2014.191 · Cited by 430
DSouza, A. V., Lin, H., Henderson, E. R., Samkoe, K. S., & Pogue, B. W. (2016) · Journal of Biomedical Optics · doi:10.1117/1.jbo.21.8.080901 · Cited by 414
Precise nanomedicine for intelligent therapy of cancer
Chen, H., Gu, Z., An, H., Chen, C., Chen, J., Cui, R., Chen, S., Chen, W., Chen, X., Chen, X., et al. (2018) · Science China Chemistry · doi:10.1007/s11426-018-9397-5 · Cited by 409
Self-citationZhu, S., Hu, Z., Tian, R., Yung, B. C., Yang, Q., Zhao, S., Kiesewetter, D. O., Niu, G., Sun, H., Antaris, A. L., et al. (2018) · Advanced Materials · doi:10.1002/adma.201802546 · Cited by 349
Self-citationNIR-II light in clinical oncology: opportunities and challenges
Zhang, Z., Du, Y., Shi, X., Wang, K., Qu, Q., Liang, Q., Ma, X., He, K., Chi, C., Tang, J., et al. (2024) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-024-00892-0 · Cited by 341
Self-citationNear-Infrared-II (NIR-II) Bioimaging via Off-Peak NIR-I Fluorescence Emission
Zhu, S., Yung, B. C., Chandra, S., Niu, G., Antaris, A. L., & Chen, X. (2018) · Theranostics · doi:10.7150/thno.27995 · Cited by 303
Self-citationFerritin nanocages: A biological platform for drug delivery, imaging and theranostics in cancer
Truffi, M., Fiandra, L., Sorrentino, L., Monieri, M., Corsi, F., & Mazzucchelli, S. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.03.002 · Cited by 277
Albumin-chaperoned cyanine dye yields superbright NIR-II fluorophore with enhanced pharmacokinetics
Tian, R., Zeng, Q., Zhu, S., Lau, J., Chandra, S., Ertsey, R., Hettie, K. S., Teraphongphom, T., Hu, Z., Niu, G., et al. (2019) · Science Advances · doi:10.1126/sciadv.aaw0672 · Cited by 266
Self-citationIn vivo fluorescence imaging: success in preclinical imaging paves the way for clinical applications
Refaat, A., Yap, M. L., Pietersz, G., Walsh, A. P. G., Zeller, J., del Rosal, B., Wang, X., & Peter, K. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01648-7 · Cited by 266
Liu, H.-Y., Wu, P.-J., Kuo, S.-Y., Chen, C.-P., Chang, E.-H., Wu, C.-Y., & Chan, Y.-H. (2015) · Journal of the American Chemical Society · doi:10.1021/jacs.5b06710 · Cited by 181
He, K., Chi, C., Kou, D., Huang, W., Wu, J., Wang, Y., He, L., Ye, J., Mao, Y., Zhang, G.-J., et al. (2016) · Translational Research · doi:10.1016/j.trsl.2016.07.010 · Cited by 46
Self-citation
Metadata
- Authors
- Chi, C., Du, Y., Ye, J., Kou, D., Qiu, J., Wang, J., Tian, J., & Chen, X.
- Venue
- Theranostics
- Publisher
- Ivyspring International Publisher
- Published
- 2014
- Volume
- 4
- Issue
- 11
- Pages
- 1072-1084
- ISSN
- 1838-7640 (ISSN-L)
- OpenAlex
- W2144903953
- Cited by
- 358
- References
- 102
- FWCI
- 26.70
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.